For end-user, the price would be Rs 400 a dose, including taxes and administration charges, added the pharmaceutical company. Earlier in April, the Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company.

Corbevax is currently being administered to children in the age group of 12-14.

Biological E Limited has manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the Central Government.

Currently, over 3 crore doses of Corbevax have been administered to children between 12-15 years of age.

COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin.

The drive later expanded on March 16 to include children aged above 12 for Corbevax. India is currently administering two COVID-19 vaccines for children above 12. (ANI)